Loading...

Matthew Kirkpatrick, PhD

TitleAssistant Professor of Research Preventive Medicine
InstitutionUniversity of Southern California
DepartmentPreventive Medicine
AddressSSB 2001 N Soto St
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 442 8221
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Matt Kirkpatrick, PhD is an Assistant Professor of Research in the Department of Preventive Medicine in the Keck School of Medicine at the University of Southern California. He is associate director of the USC-Health, Emotion, & Addiction Laboratory (USC-HEAL), which conducts interdisciplinary research at the intersection between drug abuse, emotion, and health-related behaviors. He earned his B.A. in Religious Studies at the University of North Carolina at Chapel Hill and Ph.D. in Psychology at Columbia University. Dr. Kirkpatrick completed postdoctoral training in neuropsychopharmacology at the University of Chicago.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Pester MS, Kirkpatrick M, Geary BA, Leventhal AM. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers. J Psychopharmacol. 2018 Mar; 32(3):302-308. PMID: 29338486.
      View in: PubMed
    2. MacKillop J, Goldenson NI, Kirkpatrick M, Leventhal AM. Validation of a behavioral economic purchase task for assessing drug abuse liability. Addict Biol. 2018 Jan 05. PMID: 29314376.
      View in: PubMed
    3. Pang RD, Liautaud MM, Kirkpatrick M, Huh J, Monterosso J, Leventhal AM. Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory. Neuropsychopharmacology. 2018 Mar; 43(4):828-837. PMID: 28905874.
      View in: PubMed
    4. Escobedo P, Cruz TB, Tsai KY, Allem JP, Soto DW, Kirkpatrick M, Pattarroyo M, Unger JB. Monitoring tobacco brand websites to understand marketing strategies aimed at tobacco product users and potential users. Nicotine Tob Res. 2017 Sep 11. PMID: 29059386.
      View in: PubMed
    5. Guillot CR, Halliday TM, Kirkpatrick M, Pang RD, Leventhal AM. Anhedonia and Abstinence as Predictors of the Subjective Pleasantness of Positive, Negative, and Smoking-Related Pictures. Nicotine Tob Res. 2017 Jun 01; 19(6):743-749. PMID: 28186553.
      View in: PubMed
    6. Chuang CI, Sussman S, Stone MD, Pang RD, Chou CP, Leventhal AM, Kirkpatrick M. Impulsivity and history of behavioral addictions are associated with drug use in adolescents. Addict Behav. 2017 Nov; 74:41-47. PMID: 28570913.
      View in: PubMed
    7. Kirkpatrick M, Cruz TB, Goldenson NI, Allem JP, Chu KH, Pentz MA, Unger JB. Electronic cigarette retailers use Pokémon Go to market products. Tob Control. 2017 Dec; 26(e2):e145-e147. PMID: 28044010.
      View in: PubMed
    8. Leventhal AM, Kirkpatrick M, Pester MS, McGeary JE, Swift RM, Sussman S, Kahler CW. Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology (Berl). 2017 Jan; 234(2):307-315. PMID: 27771748.
      View in: PubMed
    9. Goldenson NI, Kirkpatrick M, Barrington-Trimis JL, Pang RD, McBeth JF, Pentz MA, Samet JM, Leventhal AM. Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology. Drug Alcohol Depend. 2016 11 01; 168:176-180. PMID: 27676583.
      View in: PubMed
    10. Francis SM, Kirkpatrick M, de Wit H, Jacob S. Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration. Psychoneuroendocrinology. 2016 Dec; 74:92-100. PMID: 27592327.
      View in: PubMed
    11. Wolitzky-Taylor K, McBeth J, Guillot CR, Stone MD, Kirkpatrick M, Zvolensky MJ, Buckner JD, Leventhal AM. Transdiagnostic processes linking anxiety symptoms and substance use problems among adolescents. J Addict Dis. 2016 Jul 18; 1-12. PMID: 27431313.
      View in: PubMed
    12. Sussman S, Chou CP, Pang RD, Kirkpatrick M, Guillot CR, Stone M, Khoddam R, Riggs NR, Unger JB, Leventhal AM. Social Self-Control Is a Statistically Nonredundant Correlate of Adolescent Substance Use. Subst Use Misuse. 2016 May 11; 51(6):788-94. PMID: 27070833.
      View in: PubMed
    13. Pang RD, Kirkpatrick M, Goldenson NI, Guillot CR, Leventhal AM. Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures. Pharmacol Biochem Behav. 2016 May; 144:73-7. PMID: 26952590; PMCID: PMC4821659 [Available on 05/01/17].
    14. Bershad AK, Weafer JJ, Kirkpatrick M, Wardle MC, Miller MA, de Wit H. Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9. PMID: 26787430.
      View in: PubMed
    15. Pang RD, Bello MS, Stone MD, Kirkpatrick M, Huh J, Monterosso J, Haselton MG, Fales MR, Leventhal AM. Premenstrual symptoms and smoking-related expectancies. Addict Behav. 2016 Jun; 57:38-41. PMID: 26869196; PMCID: PMC4775430 [Available on 06/01/17].
    16. Huh J, Cerrada CJ, Kirkpatrick M, Dunton G, Leventhal AM. Social contexts of momentary craving to smoke among Korean American emerging adults. Addict Behav. 2016 May; 56:23-9. PMID: 26802789.
      View in: PubMed
    17. Leventhal AM, Strong DR, Sussman S, Kirkpatrick M, Unger JB, Barrington-Trimis JL, Audrain-McGovern J. Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016 Feb; 73:71-8. PMID: 26688438; PMCID: PMC4738156 [Available on 02/01/17].
    18. Kirkpatrick M, Goldenson NI, Kapadia N, Kahler CW, de Wit H, Swift RM, McGeary JE, Sussman S, Leventhal AM. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl). 2016 Jan; 233(1):89-97. PMID: 26429791; PMCID: PMC4703469 [Available on 01/01/17].
    19. van den Berg SM, de Moor MH, Verweij KJ, Krueger RF, Luciano M, Arias Vasquez A, Matteson LK, Derringer J, Esko T, Amin N, Gordon SD, Hansell NK, Hart AB, Seppälä I, Huffman JE, Konte B, Lahti J, Lee M, Miller M, Nutile T, Tanaka T, Teumer A, Viktorin A, Wedenoja J, Abdellaoui A, Abecasis GR, Adkins DE, Agrawal A, Allik J, Appel K, Bigdeli TB, Busonero F, Campbell H, Costa PT, Smith GD, Davies G, de Wit H, Ding J, Engelhardt BE, Eriksson JG, Fedko IO, Ferrucci L, Franke B, Giegling I, Grucza R, Hartmann AM, Heath AC, Heinonen K, Henders AK, Homuth G, Hottenga JJ, Iacono WG, Janzing J, Jokela M, Karlsson R, Kemp JP, Kirkpatrick M, Latvala A, Lehtimäki T, Liewald DC, Madden PA, Magri C, Magnusson PK, Marten J, Maschio A, Mbarek H, Medland SE, Mihailov E, Milaneschi Y, Montgomery GW, Nauck M, Nivard MG, Ouwens KG, Palotie A, Pettersson E, Polasek O, Qian Y, Pulkki-Råback L, Raitakari OT, Realo A, Rose RJ, Ruggiero D, Schmidt CO, Slutske WS, Sorice R, Starr JM, St Pourcain B, Sutin AR, Timpson NJ, Trochet H, Vermeulen S, Vuoksimaa E, Widen E, Wouda J, Wright MJ, Zgaga L. Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium. Behav Genet. 2016 Mar; 46(2):170-82. PMID: 26362575.
      View in: PubMed
    20. Goldenson NI, Kirkpatrick M, Leventhal AM. Initial Validation of the Pleasure and Health Behavior Inventory - A Measure of Motivation to Engage in Health-damaging Behavior to Overcome Deficient Pleasure. Am J Health Behav. 2015 Sep; 39(5):652-64. PMID: 26248175.
      View in: PubMed
    21. Leventhal AM, Strong DR, Kirkpatrick M, Unger JB, Sussman S, Riggs NR, Stone MD, Khoddam R, Samet JM, Audrain-McGovern J. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015 Aug 18; 314(7):700-7. PMID: 26284721; PMCID: PMC4771179.
    22. Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. JAMA Psychiatry. 2015 Jul; 72(7):642-50. PMID: 25993607.
      View in: PubMed
    23. Leventhal AM, Bello MS, Unger JB, Strong DR, Kirkpatrick M, Audrain-McGovern J. Diminished Alternative Reinforcement as a Mechanism Underlying Socioeconomic Disparities in Adolescent Substance Use. Prev Med. 2015 Nov; 80:75-81. PMID: 26051200; PMCID: PMC4592420 [Available on 11/01/16].
    24. Bershad AK, Kirkpatrick M, Seiden JA, de Wit H. Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12. PMID: 25853370; PMCID: PMC4414800.
    25. Guillot CR, Stone MD, Geary BA, Kirkpatrick M, Tidey JW, Cook JW, Leventhal AM. Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study. Hum Psychopharmacol. 2015 Sep; 30(5):364-71. PMID: 26010521; PMCID: PMC4565749.
    26. Baggott MJ, Kirkpatrick M, Bedi G, de Wit H. Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77. PMID: 25922420; PMCID: PMC4698152.
    27. Kirkpatrick M, Delton AW, Robertson TE, de Wit H. Prosocial effects of MDMA: A measure of generosity. J Psychopharmacol. 2015 Jun; 29(6):661-8. PMID: 25735993.
      View in: PubMed
    28. Wolitzky-Taylor K, Guillot CR, Pang RD, Kirkpatrick M, Zvolensky MJ, Buckner JD, Leventhal AM. Examination of anxiety sensitivity and distress tolerance as transdiagnostic mechanisms linking multiple anxiety pathologies to alcohol use problems in adolescents. Alcohol Clin Exp Res. 2015 Mar; 39(3):532-9. PMID: 25706521; PMCID: PMC4411227.
    29. Kirkpatrick M, de Wit H. MDMA: a social drug in a social context. Psychopharmacology (Berl). 2015 Mar; 232(6):1155-63. PMID: 25281223; PMCID: PMC4339498.
    30. Kirkpatrick M, Francis SM, Lee R, de Wit H, Jacob S. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology. 2014 Aug; 46:23-31. PMID: 24882155; PMCID: PMC4088952.
    31. Wardle MC, Kirkpatrick M, de Wit H. 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81. PMID: 24682132; PMCID: PMC4127030.
    32. Kirkpatrick M, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H. MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905. PMID: 24633447; PMCID: PMC4161650.
    33. Kirkpatrick M, Lee R, Wardle MC, Jacob S, de Wit H. Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63. PMID: 24448644; PMCID: PMC4023138.
    34. Kirkpatrick M, de Wit H. In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl). 2013 Nov; 230(2):215-26. PMID: 23712603; PMCID: PMC3800265.
    35. Gunderson EW, Kirkpatrick M, Willing LM, Holstege CP. Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine. J Addict Med. 2013 May-Jun; 7(3):163-8. PMID: 23732955.
      View in: PubMed
    36. Kirkpatrick M, Johanson CE, de Wit H. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64. PMID: 23343596; PMCID: PMC4241296.
    37. Kirkpatrick M, Gunderson EW, Johanson CE, Levin FR, Foltin RW, Hart CL. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction. 2012 Apr; 107(4):783-91. PMID: 22050030; PMCID: PMC3475187.
    38. Kirkpatrick M, Gunderson EW, Levin FR, Foltin RW, Hart CL. Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):191-204. PMID: 21748253; PMCID: PMC3220757.
    39. Kirkpatrick M, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL. A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):109-22. PMID: 21713605; PMCID: PMC4430833.
    40. Kirkpatrick M, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL. Zolpidem does not serve as reinforcer in humans subjected to simulated shift work. Drug Alcohol Depend. 2010 Nov 01; 112(1-2):168-71. PMID: 20655669.
      View in: PubMed
    41. Kirkpatrick M, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL. Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes. Psychopharmacology (Berl). 2009 May; 203(4):771-80. PMID: 19052727.
      View in: PubMed
    42. Perez AY, Kirkpatrick M, Gunderson EW, Marrone G, Silver R, Foltin RW, Hart CL. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):258-62. PMID: 18078723; PMCID: PMC2267907.
    43. Kirkpatrick M, Metcalfe J, Greene MJ, Hart CL. Effects of intranasal methamphetamine on metacognition of agency. Psychopharmacology (Berl). 2008 Mar; 197(1):137-44. PMID: 18043908.
      View in: PubMed
    44. Hart CL, Gunderson EW, Perez A, Kirkpatrick M, Thurmond A, Comer SD, Foltin RW. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology. 2008 Jul; 33(8):1847-55. PMID: 17851535; PMCID: PMC4918768.